| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | 3 | 3 | 0 | 0% | -4.4% | -3.7% |
| 3d | 3 | 3 | 0 | 0% | -4.4% | -3.7% |
| 1w | 3 | 3 | 1 | 33% | -8.9% | -14.3% |
| 1m | 3 | 3 | 0 | 0% | -26.3% | -23.3% |
| 3m | 3 | 3 | 1 | 33% | +18.8% | -8.9% |
| 6m | 3 | 3 | 1 | 33% | -8.0% | -13.9% |
| 1y | 0 | 0 | 0 | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
Years of dilution and R&D have created market aversion despite optical technology nearing adoption phase. Valuation is tiny relative to upside if optical tech achieves scale, offering 5-10x return potential.
Lumped in with hype AI stocks but generating real sales with Microsoft partnership and existing clients. Valuation doesn't reflect current business reality, creating 5-10x upside opportunity if market reprices the actual revenue.
Market prices in revenue as fake or unrepeatable despite existing government and enterprise customers with significant backlog. Stock can 5-10x if a portion of backlog converts to steady revenue, valuation currently reflects downside case.
End of results.